Cargando…
Critical appraisal of ticagrelor in the management of acute coronary syndrome
Ticagrelor is a novel P2Y(12) receptor antagonist which, like clopidogrel and prasugrel, functions by blocking adenosine diphosphate-mediated platelet aggregation. However, unlike the aforementioned agents, the binding of ticagrelor to this receptor is reversible. Ticagrelor is also believed to medi...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253754/ https://www.ncbi.nlm.nih.gov/pubmed/22241944 http://dx.doi.org/10.2147/TCRM.S19835 |